Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 44.33% vs 11.98% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 30.17% vs 18.19% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 35.93% vs 41.19% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 84.20% vs -0.04% in Mar 2024
Compare Profit and Loss Results of Raaj Medisafe
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
62.00
406.00
-344.00
-84.73%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
62.00
406.00
-344.00
-84.73%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
6.00
-6.00
-100.00%
Raw Materials Consumed
44.00
299.00
-255.00
-85.28%
Power & Fuel Cost
2.00
10.00
-8.00
-80.00%
Employee Cost
3.00
40.00
-37.00
-92.50%
Operating Expenses
1.00
4.00
-3.00
-75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
9.00
-8.00
-88.89%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
4.00
-4.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
53.00
380.00
-327.00
-86.05%
Operating Profit (PBDIT) excl Other Income
8.00
26.00
-18.00
-69.23%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
8.00
31.00
-23.00
-74.19%
Interest
2.00
6.00
-4.00
-66.67%
Profit before Depriciation and Tax
6.00
24.00
-18.00
-75.00%
Depreciation
1.00
8.00
-7.00
-87.50%
Profit Before Taxation & Exceptional Items
5.00
16.00
-11.00
-68.75%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
16.00
-11.00
-68.75%
Provision for Tax
0.00
3.00
-3.00
-100.00%
Profit After Tax
6.00
12.00
-6.00
-50.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-2.00
159.00
-161.00
-101.26%
Profit Available for appropriations
3.00
172.00
-169.00
-98.26%
Appropriations
3.00
172.00
-169.00
-98.26%
Equity Dividend (%)
0%
8%
-8.00
Earnings Per Share
4.6
11.19
-6.59
-58.89%
Profit And Loss - Net Sales
Net Sales 62.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 44.33% vs 11.98% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.63 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.17% vs 18.19% in Mar 2024
Profit And Loss - Interest
Interest 2.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 35.93% vs 41.19% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 6.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 84.20% vs -0.04% in Mar 2024






